Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Zhengguo Wu, Shang Li, Xiao Zhu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma
Mingyu Du, Yi Peng, Li Yang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 44
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
Meiqi Duan, Haiyang Liu, Shasha Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 890-920
Open Access | Times Cited: 23
Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 8
RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines
Hui Dong, Haidong Zhang, Xinyu Mao, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1084-1084
Open Access | Times Cited: 20
Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
Chen Da-hong, Jigang Zhang, Chuan-Xing Wu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
RNA m6Amethylation in cancer
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
Chengjie Lin, Yan Wang, Yihong Dong, et al.
Biology Direct (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer
Qianyi Lin, Ming Zhang, Ying Kong, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13811-e13811
Open Access | Times Cited: 12
The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification
Jingyu Wang, Xiaoli Guo, Yujiao Chen, et al.
Toxicology (2024) Vol. 503, pp. 153758-153758
Closed Access | Times Cited: 4
N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration
Tong Zhao, Jianni Qi, Tiantian Liu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
FAT1 inhibits the proliferation of DLBCL cells via increasing the m6A modification of YAP1 mRNA
Tianlong Wang, Xiaojuan Miao, Yanrong Shuai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma
Zimo Zhou, Tiantong Zhu, Senxiang Chen, et al.
Current Cancer Drug Targets (2022) Vol. 22, Iss. 4, pp. 340-350
Closed Access | Times Cited: 14
Identification of ferroptosis related markers by integrated bioinformatics analysis and In vitro model experiments in rheumatoid arthritis
Jinjun Xia, Lulu Zhang, Tao Gu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Retracted: METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B‐cell lymphoma cells
Lili Feng, Qinying Yan, Hui Pan, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 5
The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
Shuzhen Tan, Zesong Li, Kai Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 9
The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression
Pia Fahmé, Farah Ramadan, Diep Tien Le, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6043-6043
Open Access | Times Cited: 5
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside
Chenchen Ma, Peng Liu, Siyuan Cui, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5804-5804
Open Access | Times Cited: 3
Internal m6A and m7G RNA modifications in hematopoietic system and acute myeloid leukemia
Xiaoxu Zhang, Yanni Ma, Jia Yu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 9, pp. 1033-1043
Open Access
Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2′-O-methylation as targets for novel therapeutic strategies
Cornelius Pauli, Michael Kienhöfer, Stefanie Göllner, et al.
Biological Chemistry (2021) Vol. 402, Iss. 12, pp. 1531-1546
Closed Access | Times Cited: 4
Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma
Cong Wang, Ran Kong, Guangcai Zhong, et al.
Molecular Biotechnology (2024)
Closed Access
Predicting pan-cancer immune-checkpoint therapy and prognosis with a chromatin-accessibility-related alternative splicing signature: a retrospective study
Yitong Li, Feifei Lan, Yi‐Ling Lin, et al.
International Journal of Surgery Oncology (2024)
Open Access
The Tumor Stemness Indice mRNAsi can Act as Molecular Typing Tool for Lung Adenocarcinoma
Yunmeng Yi, Xiaoqi Liu, Hanyu Gao, et al.
Biochemical Genetics (2023) Vol. 61, Iss. 6, pp. 2401-2424
Closed Access | Times Cited: 1
Potential Correlation Between Eczema and Hematological Malignancies Risk: A Systematic Review and Meta-Analysis
Zuohui Liang, Jie Liu, Hongxia Jin, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top